EUVIMEDEUVIMED entdecken
Crossref

The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction

Tufan Çınar iD, Faysal Şaylık iD, Mert İlker Hayıroğlu iD, Suha Asal, Murat Selçuk, Vedat Çiçek, İbrahim Halil Tanboğa

Angiology · 2023-04 · 74 (4) · 381-386

DOI: 10.1177/00033197221110700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, online erschienen am 21.06.2022. Verfasst von Tufan Çınar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, 506079Istanbul Sultan II Abdülhamid Han Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The goal of this investigation was to explore the relationship between serum uric acid/albumin ratio (UAR) and no-reflow (NR) in ST elevation myocardial infarction (STEMI) patients (n = 838) who underwent primary percutaneous coronary intervention (pPCI). Angiographic NR was defined as thrombolysis in myocardial infarction (TIMI) flows 0, 1, and 2 in the absence of coronary spasm or dissection. NR developed in 91 (10.9%) STEMI patients. Patients with NR had higher UAR and according to multivariable logistic regression models, a high UAR was an independent risk factor for NR. The area under the curve (AUC) value of the UAR was .760 (95%CI: .720-.801) in a receiver-operating characteristics curve (ROC) assessment. Notably, the UAR AUC value was greater than that of its components: albumin (AUC: .642) and serum uric acid (AUC: .637) ( P < .05 for both comparisons). The optimum UAR value in detecting NR in STEMI patients was >1.21 with a sensitivity of 82% and a specificity of 67%. This was the first study to report that the UAR was independently associated with NR in STEMI patients who underwent pPCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionPercutaneous Coronary InterventionNo-Reflow PhenomenonHumansUric AcidPrognosisCoronary AngiographyAlbumins

Stichwörter der Autor:innen

ST elevation myocardial infarctionno-reflowprimary percutaneous coronary interventionuric acid/albumin ratio

Substanzen

Uric AcidAlbumins

Autor:innen und Institutionen

  • Department of Cardiology, 506079Istanbul Sultan II Abdülhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Department of Cardiology, 64259Van Training and Research Hospital, Van, Turkey.
  • Department of Cardiology, 111319Siyami Ersek Training and Research Hospital, Istanbul, Turkey.
  • Department of Cardiology, Hisar Intercontinental Hospital, Istanbul, Turkey.
  • Department of Cardiology, 385796Nisantası University, Istanbul, Turkey.
  • Department of Biostatistics, Atatürk University, Erzurum, Turkey.

ORCID-Profile: Tufan Çınar, Faysal Şaylık, Mert İlker Hayıroğlu

Zitieren

APA

Çınar, T., Şaylık, F., Hayıroğlu, M. İ., Asal, S., Selçuk, M., Çiçek, V., & Tanboğa, İ. H. (2023). The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction. Angiology, 74(4), 381-386. https://doi.org/10.1177/00033197221110700

Vancouver

Çınar T, Şaylık F, Hayıroğlu Mİ, Asal S, Selçuk M, Çiçek V, et al. The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction. Angiology. 2023;74(4):381-386. doi:10.1177/00033197221110700

BibTeX
@article{nar2023,
  author = {Çınar, Tufan and Şaylık, Faysal and Hayıroğlu, Mert İlker and Asal, Suha and Selçuk, Murat and Çiçek, Vedat and Tanboğa, İbrahim Halil},
  title = {The Association of Serum Uric Acid/Albumin Ratio with No-Reflow in Patients with ST Elevation Myocardial Infarction},
  journal = {Angiology},
  year = {2023},
  volume = {74},
  number = {4},
  pages = {381--386},
  doi = {10.1177/00033197221110700}
}
Kostenlos starten →